BondTrue is a startup specializing in medical device design and development, with a focus on improving surgical closure for better wound healing. The company's flagship product, BondTrue, is currently under development and is the first patented product in its portfolio. It introduces a novel approach to surgical closure by accurately realigning the wound back together, thereby reducing complications and ultimately saving time and costs.
Founded in 2016, BondTrue operates within the biotechnology, health care, manufacturing, and medical devices industries. It is headquartered in the United States.
As of now, there is no public information available regarding their last investment or the involved investors.